Filing Details

Accession Number:
0000899243-16-016827
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-03-29 18:38:24
Reporting Period:
2016-03-28
Filing Date:
2016-03-29
Accepted Time:
2016-03-29 18:38:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
887359 Vericel Corp VCEL Biological Products, (No Disgnostic Substances) (2836) 943096597
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1097955 Md J Mitchell Blutt 1370 Avenue Of The Americas
Suite 3301
New York NY 10019
No No Yes No
1544773 Consonance Capital Management Lp 1370 Avenue Of The Americas
Suite 3301
New York NY 10019
No No Yes No
1620428 Consonance Capman Gp, Llc 1370 Avenue Of The Americas
Suite 3301
New York NY 10019
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-03-28 120,000 $5.39 2,232,940 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
Footnotes
  1. Consonance Capital Management LP ("Management") is the indirect beneficial owner of the shares of Common Stock, no par value, held by Consonance Capital Master Account, LP (the "Master Account"). Consonance Capman GP, LLC ("Capman") is the general partner of Management. Management receives an asset-based fee, but has no pecuniary interest. Mitchell Blutt is the manager and member of Capman and has a pecuniary interest in the shares held by the Master Account as the manager and member of the general partner of the Master Account and thereby is entitled to a portion of the profits allocation. Each of Mr. Blutt, Management and Capman disclaims their beneficial ownership except to the extent of their pecuniary interest.